FAct: A Non-interventional Multi-center Study to Follow Patients Starting With RoActemra Assessing the Long Term Efficacy, Effectiveness and Safety of RoActemra.
Phase of Trial: Phase IV
Latest Information Update: 03 Oct 2017
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms FACT
- Sponsors Roche
- 27 Sep 2017 Status changed from active, no longer recruiting to completed.
- 10 Jun 2017 Biomarkers information updated
- 25 Sep 2013 Planned End Date changed from 1 Dec 2017 to 1 Feb 2017 as reported by ClinicalTrials.gov.